annual EBIT:
$219.40M-$498.59M(-69.44%)Summary
- As of today (May 29, 2025), CRL annual earnings before interest & taxes is $219.40 million, with the most recent change of -$498.59 million (-69.44%) on December 28, 2024.
- During the last 3 years, CRL annual EBIT has fallen by -$335.22 million (-60.44%).
- CRL annual EBIT is now -69.44% below its all-time high of $717.99 million, reached on December 30, 2023.
Performance
CRL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$63.86M+$252.42M(+133.87%)Summary
- As of today (May 29, 2025), CRL quarterly earnings before interest & taxes is $63.86 million, with the most recent change of +$252.42 million (+133.87%) on March 29, 2025.
- Over the past year, CRL quarterly EBIT has dropped by -$70.15 million (-52.35%).
- CRL quarterly EBIT is now -77.17% below its all-time high of $279.70 million, reached on December 31, 2022.
Performance
CRL quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$149.25M-$70.15M(-31.97%)Summary
- As of today (May 29, 2025), CRL TTM earnings before interest & taxes is $149.25 million, with the most recent change of -$70.15 million (-31.97%) on March 29, 2025.
- Over the past year, CRL TTM EBIT has dropped by -$537.33 million (-78.26%).
- CRL TTM EBIT is now -80.24% below its all-time high of $755.44 million, reached on September 30, 2023.
Performance
CRL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CRL EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -69.4% | -52.4% | -78.3% |
3 y3 years | -60.4% | -46.9% | -74.2% |
5 y5 years | -39.9% | -9.4% | -58.5% |
CRL EBIT Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -69.4% | at low | -77.2% | +133.9% | -80.2% | at low |
5 y | 5-year | -69.4% | at low | -77.2% | +133.9% | -80.2% | at low |
alltime | all time | -69.4% | +149.1% | -77.2% | +109.8% | -80.2% | +129.1% |
CRL EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $63.86M(-133.9%) | $149.25M(-32.0%) |
Dec 2024 | $219.40M(-69.4%) | -$188.56M(-255.2%) | $219.40M(-66.3%) |
Sep 2024 | - | $121.53M(-20.3%) | $650.21M(-3.7%) |
Jun 2024 | - | $152.42M(+13.7%) | $675.30M(-1.6%) |
Mar 2024 | - | $134.01M(-44.7%) | $686.59M(-4.4%) |
Dec 2023 | $717.99M(+5.2%) | $242.25M(+65.2%) | $717.99M(-5.0%) |
Sep 2023 | - | $146.62M(-10.4%) | $755.44M(+1.6%) |
Jun 2023 | - | $163.71M(-1.0%) | $743.31M(+2.2%) |
Mar 2023 | - | $165.42M(-40.9%) | $727.42M(+6.6%) |
Dec 2022 | $682.28M(+23.0%) | $279.70M(+108.0%) | $682.28M(+18.1%) |
Sep 2022 | - | $134.48M(-9.0%) | $577.77M(-0.9%) |
Jun 2022 | - | $147.82M(+22.9%) | $583.01M(+0.7%) |
Mar 2022 | - | $120.28M(-31.3%) | $578.88M(+4.4%) |
Dec 2021 | $554.62M(+3.9%) | $175.19M(+25.4%) | $554.62M(-5.2%) |
Sep 2021 | - | $139.72M(-2.8%) | $585.01M(-2.4%) |
Jun 2021 | - | $143.69M(+49.6%) | $599.42M(+7.2%) |
Mar 2021 | - | $96.02M(-53.3%) | $559.04M(+4.8%) |
Dec 2020 | $533.55M(+46.2%) | $205.57M(+33.4%) | $533.55M(+16.5%) |
Sep 2020 | - | $154.14M(+49.2%) | $457.90M(+19.7%) |
Jun 2020 | - | $103.30M(+46.5%) | $382.69M(+6.5%) |
Mar 2020 | - | $70.53M(-45.7%) | $359.21M(-1.6%) |
Dec 2019 | $364.97M(+5.6%) | $129.93M(+64.6%) | $364.97M(+11.7%) |
Sep 2019 | - | $78.93M(-1.1%) | $326.83M(-3.4%) |
Jun 2019 | - | $79.83M(+4.7%) | $338.40M(-2.6%) |
Mar 2019 | - | $76.28M(-16.9%) | $347.50M(+0.6%) |
Dec 2018 | $345.45M(+5.7%) | $91.79M(+1.4%) | $345.45M(+4.5%) |
Sep 2018 | - | $90.50M(+1.8%) | $330.44M(+3.1%) |
Jun 2018 | - | $88.93M(+19.8%) | $320.55M(+1.5%) |
Mar 2018 | - | $74.23M(-3.3%) | $315.93M(-3.3%) |
Dec 2017 | $326.73M(+30.4%) | $76.78M(-4.8%) | $326.73M(+1.7%) |
Sep 2017 | - | $80.61M(-4.4%) | $321.19M(+6.7%) |
Jun 2017 | - | $84.32M(-0.8%) | $300.92M(+7.5%) |
Mar 2017 | - | $85.03M(+19.4%) | $279.90M(+11.7%) |
Dec 2016 | $250.63M(+19.1%) | $71.23M(+18.1%) | $250.63M(+7.5%) |
Sep 2016 | - | $60.34M(-4.7%) | $233.21M(+1.4%) |
Jun 2016 | - | $63.30M(+13.5%) | $229.88M(-0.6%) |
Mar 2016 | - | $55.76M(+3.6%) | $231.28M(+9.9%) |
Dec 2015 | $210.50M(+11.1%) | $53.81M(-5.6%) | $210.50M(+5.4%) |
Sep 2015 | - | $57.01M(-11.9%) | $199.65M(+5.3%) |
Jun 2015 | - | $64.70M(+85.0%) | $189.52M(+6.0%) |
Mar 2015 | - | $34.98M(-18.6%) | $178.73M(-5.7%) |
Dec 2014 | $189.54M(+19.0%) | $42.97M(-8.3%) | $189.54M(+9.9%) |
Sep 2014 | - | $46.88M(-13.0%) | $172.51M(+1.1%) |
Jun 2014 | - | $53.91M(+17.7%) | $170.68M(+5.9%) |
Mar 2014 | - | $45.79M(+76.6%) | $161.16M(+1.2%) |
Dec 2013 | $159.30M(-2.3%) | $25.93M(-42.4%) | $159.30M(-5.1%) |
Sep 2013 | - | $45.05M(+1.5%) | $167.88M(+5.1%) |
Jun 2013 | - | $44.39M(+1.1%) | $159.75M(-2.3%) |
Mar 2013 | - | $43.93M(+27.3%) | $163.44M(+0.2%) |
Dec 2012 | $163.09M | $34.51M(-6.5%) | $163.09M(-4.7%) |
Sep 2012 | - | $36.91M(-23.2%) | $171.19M(+0.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2012 | - | $48.08M(+10.3%) | $170.77M(-3.1%) |
Mar 2012 | - | $43.58M(+2.3%) | $176.15M(+0.5%) |
Dec 2011 | $175.25M(-158.7%) | $42.62M(+16.8%) | $175.25M(-175.9%) |
Sep 2011 | - | $36.48M(-31.8%) | -$230.83M(-12.0%) |
Jun 2011 | - | $53.46M(+25.3%) | -$262.25M(-8.4%) |
Mar 2011 | - | $42.68M(-111.7%) | -$286.21M(-4.2%) |
Dec 2010 | -$298.80M(-272.5%) | -$363.46M(-7278.7%) | -$298.80M(-401.9%) |
Sep 2010 | - | $5.06M(-82.8%) | $98.98M(-29.3%) |
Jun 2010 | - | $29.51M(-1.9%) | $139.93M(-14.2%) |
Mar 2010 | - | $30.08M(-12.4%) | $163.06M(-5.9%) |
Dec 2009 | $173.24M(-138.8%) | $34.33M(-25.4%) | $173.24M(-133.7%) |
Sep 2009 | - | $46.01M(-12.6%) | -$513.70M(+4.7%) |
Jun 2009 | - | $52.64M(+30.7%) | -$490.64M(+3.9%) |
Mar 2009 | - | $40.26M(-106.2%) | -$472.18M(+5.6%) |
Dec 2008 | -$447.00M(-289.9%) | -$652.61M(-1044.8%) | -$447.00M(-268.1%) |
Sep 2008 | - | $69.08M(-2.8%) | $265.98M(+2.1%) |
Jun 2008 | - | $71.10M(+8.6%) | $260.54M(+5.8%) |
Mar 2008 | - | $65.44M(+8.4%) | $246.16M(+4.6%) |
Dec 2007 | $235.43M(+25.1%) | $60.37M(-5.1%) | $235.43M(+6.9%) |
Sep 2007 | - | $63.63M(+12.2%) | $220.21M(+5.6%) |
Jun 2007 | - | $56.73M(+3.7%) | $208.50M(+4.5%) |
Mar 2007 | - | $54.70M(+21.1%) | $199.48M(+233.5%) |
Dec 2006 | $188.17M(+1.9%) | $45.15M(-13.0%) | $59.81M(+9.5%) |
Sep 2006 | - | $51.92M(+8.8%) | $54.61M(+4.7%) |
Jun 2006 | - | $47.70M(-156.1%) | $52.18M(-2.5%) |
Mar 2006 | - | -$84.96M(-312.7%) | $53.54M(-70.9%) |
Dec 2005 | $184.69M(+16.9%) | $39.95M(-19.3%) | $183.90M(+5.2%) |
Sep 2005 | - | $49.49M(+0.9%) | $174.84M(+3.6%) |
Jun 2005 | - | $49.06M(+8.1%) | $168.72M(+3.0%) |
Mar 2005 | - | $45.40M(+47.0%) | $163.87M(+3.7%) |
Dec 2004 | $157.99M(+14.0%) | $30.89M(-28.8%) | $157.99M(-2.8%) |
Sep 2004 | - | $43.37M(-1.9%) | $162.54M(+5.9%) |
Jun 2004 | - | $44.20M(+11.9%) | $153.42M(+6.4%) |
Mar 2004 | - | $39.52M(+11.5%) | $144.22M(+4.1%) |
Dec 2003 | $138.55M(+13.3%) | $35.44M(+3.5%) | $138.55M(+3.3%) |
Sep 2003 | - | $34.26M(-2.1%) | $134.06M(+1.3%) |
Jun 2003 | - | $35.01M(+3.4%) | $132.33M(+3.6%) |
Mar 2003 | - | $33.85M(+9.3%) | $127.70M(+4.4%) |
Dec 2002 | $122.27M(+35.4%) | $30.95M(-4.8%) | $122.27M(+7.5%) |
Sep 2002 | - | $32.52M(+7.0%) | $113.72M(+8.1%) |
Jun 2002 | - | $30.38M(+6.9%) | $105.21M(+5.9%) |
Mar 2002 | - | $28.41M(+26.8%) | $99.32M(+10.0%) |
Dec 2001 | $90.28M(+38.8%) | $22.41M(-6.7%) | $90.28M(+10.6%) |
Sep 2001 | - | $24.01M(-2.0%) | $81.65M(+8.2%) |
Jun 2001 | - | $24.49M(+26.4%) | $75.48M(+9.1%) |
Mar 2001 | - | $19.37M(+40.7%) | $69.20M(+6.4%) |
Dec 2000 | $65.06M(+51.4%) | $13.77M(-22.9%) | $65.06M(+26.8%) |
Sep 2000 | - | $17.85M(-2.0%) | $51.29M(+53.4%) |
Jun 2000 | - | $18.21M(+19.6%) | $33.45M(+119.6%) |
Mar 2000 | - | $15.23M | $15.23M |
Dec 1999 | $42.96M(+21.6%) | - | - |
Dec 1998 | $35.33M | - | - |
FAQ
- What is Charles River Laboratories International annual earnings before interest & taxes?
- What is the all time high annual EBIT for Charles River Laboratories International?
- What is Charles River Laboratories International annual EBIT year-on-year change?
- What is Charles River Laboratories International quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly EBIT year-on-year change?
- What is Charles River Laboratories International TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Charles River Laboratories International?
- What is Charles River Laboratories International TTM EBIT year-on-year change?
What is Charles River Laboratories International annual earnings before interest & taxes?
The current annual EBIT of CRL is $219.40M
What is the all time high annual EBIT for Charles River Laboratories International?
Charles River Laboratories International all-time high annual earnings before interest & taxes is $717.99M
What is Charles River Laboratories International annual EBIT year-on-year change?
Over the past year, CRL annual earnings before interest & taxes has changed by -$498.59M (-69.44%)
What is Charles River Laboratories International quarterly earnings before interest & taxes?
The current quarterly EBIT of CRL is $63.86M
What is the all time high quarterly EBIT for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly earnings before interest & taxes is $279.70M
What is Charles River Laboratories International quarterly EBIT year-on-year change?
Over the past year, CRL quarterly earnings before interest & taxes has changed by -$70.15M (-52.35%)
What is Charles River Laboratories International TTM earnings before interest & taxes?
The current TTM EBIT of CRL is $149.25M
What is the all time high TTM EBIT for Charles River Laboratories International?
Charles River Laboratories International all-time high TTM earnings before interest & taxes is $755.44M
What is Charles River Laboratories International TTM EBIT year-on-year change?
Over the past year, CRL TTM earnings before interest & taxes has changed by -$537.33M (-78.26%)